Tsujiuchi Toshifumi

ツジウチトシフミ | Tsujiuchi Toshifumi

Affiliation and department：
Job title： Professor

Research field (2)： Experimental pathology , Human pathology

Research keywords (5)： oncology , cancer biology , cell signaling , 分子病理学 , molecular pathology

Research theme for competitive and other funds (12)：

2021 - 2024 LPA受容体シグナルを介するがん細胞の抗がん剤・放射線感受性調節機構の解明
2018 - 2021 Roles of LPA receptors in the acquisition of malignant properties in cancer cells treated with anticancer drugs
2015 - 2020 Translational applications of broad spectrum natural compounds and phytochemicals or their derivatives to the novel treatment strategy against sarcomas
2012 - 2015 Functional analysis of LPA receptors in the acquisition of malignant properties in cancer cells.
2012 - 2015 Abnormal LPA receptor signaling in cancer

Show all

Papers (261)：

Yamamoto M, Takai M, Yashiro N, Taniguchi A, Tamura M, Kusumoto Y, Nagano S, Tsujiuchi T. The role of LPA receptor signaling in modulating cellular responses of colon cancer cells co-cultured with lymphoid endothelial cells under hypoxic stress. Tissue and Cell. 2024. 91. 102528
Takai M, Yamamoto M, Yashiro N, Nagano S, Kusumoto Y, Tamura M, Taniguchi A, Tsujiuchi T. Impact of cellular ATP levels on cell viability in response to fluorouracil through lysophosphatidic acid (LPA) receptor-4 (LPA4) and LPA6 in colon cancer cells. Adv Biol Regul. 2024. 93. 101042
Takai M, Yamamoto M, Yashiro N, Tamura M, Taniguchi A, Nagano S, Kusumoto Y, Tsujiuchi T. FFAR-mediated signaling drives migration of pancreatic cancer cells in hypoxic fibroblast co-cultures. Biochem Biophys Res Commun. 2024. 727. 150322
Takai M, Yamamoto M, Yashiro N, Tsujiuchi T. Involvement of lysophosphatidic acid (LPA) receptor-mediated signaling in breast cancer cell functions by long-term tamoxifen treatment under hypoxic and estrogen-deprived conditions. Pathol Res Pract. 2024. 260. 155385
Takai M, Mori S, Honoki K, Tsujiuchi T. Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cancer cell biology. J Bioenerg Biomembr. 2024. 56. 475.-482

ｍore...

MISC (33)：

岸真五, 朴木寛弥, 森汐莉, 塚本真治, 近藤裕美子, 藤井宏真, 城戸顕, 谷里奈, 西口由希子, 笹平智則, et al. プテロスティルベンはF0-F1ATPシンターゼ阻害を介して骨肉腫の幹細胞性を抑制しドキソルビシンの効果を増強させる. 日本整形外科学会雑誌. 2018. 92. 6. S1461-S1461
田村和朗, 長尾哲二, 南武志, 日高雄二, 辻内俊文, 巽純子, 福嶋伸之, 加川尚, 西郷和真, 島本茂, et al. がんゲノム医療時代の遺伝カウンセラーの養成:文部科学省がんプロ養成プランへの参画. 日本人類遺伝学会大会プログラム・抄録集. 2018. 63rd. 380
岸真五, 朴木寛弥, 国安弘基, 城戸顕, 藤井宏真, 塚本真治, 近藤裕美子, 羅奕, 門地優衣, 森汐莉, et al. Pterostilbeneは骨肉腫の増殖能およびスフェア形成能を抑制しドキソルビシンの効果を増強する. 日本整形外科学会雑誌. 2017. 91. 6. S1391-S1391
Kanya Honoki, Hiromasa Fujii, Akira Kido, Shinji Tsukamoto, Toshio Mori, Yasuhito Tanaka, Toshifumi Tsujiuchi. Possible involvement of senescence bypass in mesenchymal stem cells for sarcomagenesis identified through a comparative gene expression profiling in rat sarcoma model. CANCER RESEARCH. 2015. 75
Kanya Honoki, Toshifumi Tsujiuchi. Senescence bypass in mesenchymal stem cells: apotential pathogenesis and implications of pro-senescence therapy in sarcomas. EXPERT REVIEW OF ANTICANCER THERAPY. 2013. 13. 8. 983-996

ｍore...

Books (2)：

ミネルヴァ書房, 『ケアマネジメント用語辞典(改訂版)』
2007
ミネルヴァ書房, 『ケアマネジメント用語辞典』
2005

Lectures and oral presentations (3)：

膵炎関連痛モデルにおけるメシル酸カモスタットの抗侵害受容的作用.
(第79回日本薬理学会年会 2010)
Involvement of endogenous hydrogen sulfide in acute pancreatitis-related pain.
(6th FENS Forum of European Neuroscience 2008)
Hydrogen sulfide as a nociceptive messenger in rat and mouse pancreata.
(Neuroscience 2007 2007)

Education (2)：

- 1992 Nara Medical University
- 1992 Nara Medical University Graduate School, Division of Medicine

Professional career (1)：

(BLANK)

Committee career (1)：

1994 - 日本病理学会学術評議員

Awards (1)：

2006/03 - がん研究振興財団第39回がん研究助成金

Association Membership(s) (2)：

日本病理学会 , 日本癌学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page